Scholar
Bin Chen
Google Scholar ID: K7MBJlwAAAAJ
Michigan State University
Citations & Impact
Citations
3,259
H-index
30
i10-index
55
Publications
20
Co-authors
3
list available
Publications
Browse publications on Google Scholar (top-right) ↗
Resume (English only)
Academic Achievements
- - Appointed as a standing member of the NIH BDMA study section in 2025.
- - Published multiple papers in Acta Neuropathologica Communications, JAMIA Open, etc., between 2022 and 2023.
- - Drug discovery work for SARS-COV-2 and its variants accepted in principle by iScience (Cell publishing group) in August 2022.
- - MolSearch paper won the best paper award at the 2022 KDD Health Day in June 2022.
- - Received the 2021 Early Career Research Excellence Award at CHM in November 2021.
- - First EMR/EHR data mining paper led by Dr. Ke Liu accepted by AMIA 2022 in December 2021.
- - AI-based virtual screening R01 received an outstanding score (7 percentile) in November 2021.
- - Pipeline applied to find drugs to overcome resistance in melanoma accepted by Molecular Pharmacology, featured on the cover in October 2021.
- - Drug repurposing pipeline successfully applied to Alzheimer's disease published in Nature Aging in October 2021.
Research Experience
- Closely collaborates with data mining experts, statisticians, bench scientists, medicinal chemists, and physicians to identify new therapeutics.
Background
- Research interests include OMICS-based drug discovery, OMICS-based biomarker and target discovery, and virtual platform development to support translational research. The primary data used include bulk/single cell transcriptomics, spatial transcriptomics, and EMR/EHR. In addition to traditional bioinformatics methods, actively developing and implementing new machine learning models such as transfer learning and deep reinforcement learning.
Miscellany
- The lab welcomed several interns and researchers; some members advanced or moved on to other institutions.
